GHB 50mg vs placebo be used
- Gamma‐hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses 2010 · Cochrane Headline outcomes onlyno estimate extracted1 study · 23 participantsVery low
GHB 50mg showed no clear difference in side‐effects ‐ side‐effects causing abandon compared with GHB 100 mg be used (low certainty).
GHB 50mg showed no clear difference in abstinence ‐ 6 months compared with placebo be used (low certainty).
GHB 50mg showed no clear difference in relapse to heavy drinking ‐ 6 months compared with placebo be used (low certainty).
It is very uncertain whether GHB 50mg changes abstinence ‐ 12 months compared with NTX be used (very low certainty).
It is very uncertain whether GHB 50mg changes relapses to heavy drinking ‐ 12 months compared with NTX be used (very low certainty).
GHB 50mg showed no clear difference in side‐effects ‐ side‐effects causing abandon compared with NTX be used (moderate certainty).
It is very uncertain whether GHB 50mg changes abstinence ‐ 12 months compared with disulfiram be used (very low certainty).
It is very uncertain whether GHB 50mg changes relapses to heavy drinking ‐ 12 months compared with disulfiram be used (very low certainty).
GHB 50mg may leads to higher side‐effects ‐ tolerated side‐effects compared with placebo be used (low certainty).
It is very uncertain whether GHB 50mg changes side‐effects ‐ side‐effects causing abandon compared with disulfiram be used (very low certainty).
GHB 50mg showed no clear difference in side‐effects ‐ side‐effects causing abandon compared with clomethiazole be used (low certainty).